NOVARTIS FARMACEUTICA, S.A. secures contract for Analgesics - Supply of antimigrainous medicines with the following active ingredients, Erenumab, Galcanezumab, Fremanzumab, Eptinezumab, Rimegepant, Atogepant to the centers of the Valencian public health field

Spain, Oct. 28 -- Spain based NOVARTIS FARMACEUTICA, S.A. has secured contract from Direccion General de Gestion Economica, Contratacion e Infraestructuras de la Conselleria de Sanidad for Analgesics - Supply of antimigrainous medicines with the following active ingredients, Erenumab, Galcanezumab, Fremanzumab, Eptinezumab, Rimegepant, Atogepant to the centers of the Valencian public health field. The value of the contract is worth 310302720 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....